368 related articles for article (PubMed ID: 16792544)
1. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.
Nabeshima K; Iwasaki H; Koga K; Hojo H; Suzumiya J; Kikuchi M
Pathol Int; 2006 Jul; 56(7):359-67. PubMed ID: 16792544
[TBL] [Abstract][Full Text] [Related]
2. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S
Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323
[TBL] [Abstract][Full Text] [Related]
3. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts.
Li R; Huang L; Guo H; Toole BP
J Cell Physiol; 2001 Mar; 186(3):371-9. PubMed ID: 11169976
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
5. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Tang Y; Kesavan P; Nakada MT; Yan L
Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
[TBL] [Abstract][Full Text] [Related]
6. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression.
Yan L; Zucker S; Toole BP
Thromb Haemost; 2005 Feb; 93(2):199-204. PubMed ID: 15711733
[TBL] [Abstract][Full Text] [Related]
7. Role of emmprin/CD147 in tissue remodeling.
Huet E; Gabison EE; Mourah S; Menashi S
Connect Tissue Res; 2008; 49(3):175-9. PubMed ID: 18661337
[TBL] [Abstract][Full Text] [Related]
8. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
9. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
[TBL] [Abstract][Full Text] [Related]
11. EMMPRIN (basigin/CD147) expression is not correlated with MMP activity during adult mouse mammary gland development.
Szymanowska M; Hendry KA; Robinson C; Kolb AF
J Cell Biochem; 2009 Jan; 106(1):52-62. PubMed ID: 19003972
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.
Guo H; Li R; Zucker S; Toole BP
Cancer Res; 2000 Feb; 60(4):888-91. PubMed ID: 10706100
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells.
Li QQ; Wang WJ; Xu JD; Cao XX; Chen Q; Yang JM; Xu ZD
Cancer Sci; 2007 Jul; 98(7):1064-9. PubMed ID: 17441962
[TBL] [Abstract][Full Text] [Related]
14. Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells.
Jia L; Wei W; Cao J; Xu H; Miao X; Zhang J
Ann Hematol; 2009 Aug; 88(8):753-60. PubMed ID: 19125248
[TBL] [Abstract][Full Text] [Related]
15. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
Cao Z; Xiang J; Li C
Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030
[TBL] [Abstract][Full Text] [Related]
16. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo.
Rosenthal EL; Vidrine DM; Zhang W
Laryngoscope; 2006 Jul; 116(7):1086-92. PubMed ID: 16826041
[TBL] [Abstract][Full Text] [Related]
18. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
Jodele S; Blavier L; Yoon JM; DeClerck YA
Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
[TBL] [Abstract][Full Text] [Related]
19. CD147/basigin promotes progression of malignant melanoma and other cancers.
Kanekura T; Chen X
J Dermatol Sci; 2010 Mar; 57(3):149-54. PubMed ID: 20060267
[TBL] [Abstract][Full Text] [Related]
20. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
Siwik DA; Kuster GM; Brahmbhatt JV; Zaidi Z; Malik J; Ooi H; Ghorayeb G
J Mol Cell Cardiol; 2008 Jan; 44(1):210-7. PubMed ID: 17869266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
